The possible mechanism involves that SchA encourages the AMPK/mTOR pathway activation, triggers mitochondrial dysfunction, and enhances oxidative damage, ferroptosis and apoptosis of HCC cells, thereby inhibiting HCC cells' migration, proliferation and invasion and the HCC progression. Here, MTOR is linked to hepatocellular carcinoma.